COSMOS Pharmaceutical Corp. (3349) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

MatsukiyoCocokara & Co.

Qol Holdings Co., Ltd.

Ain Holdings, Inc.

Create SD Holdings Co., Ltd.

TSURUHA Holdings, Inc.

Sundrug Co., Ltd.

Welcia Holdings Co., Ltd.

Sugi Holdings Co., Ltd.

Genky DrugStores Co., Ltd.

COSMOS Pharmaceutical Corp.

Cawachi Ltd.

Why is COSMOS Pharmaceutical Corp. ?

Weak Long Term Fundamental Strength with a 2.72% CAGR growth in Operating Profits over the last 5 years

Poor long term growth as Operating profit has grown by an annual rate 2.72% of over the last 5 years

The company has declared Negative results for the last 12 consecutive quarters

DEBT-EQUITY RATIO (HY) Highest at 6.04 %
INTEREST COVERAGE RATIO(Q) Lowest at 6,593.77
DEBTORS TURNOVER RATIO(HY) Lowest at 67.88 times

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -27.13% returns in the last 1 year, the stock has also underperformed Japan Nikkei 225 in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Retailing)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is COSMOS Pharmaceutical Corp. for you?

Low Risk, Low Return

Absolute

Risk Adjusted

Volatility

COSMOS Pharmaceutical Corp.

-27.13%

-0.04

33.40%

Japan Nikkei 225

43.52%

1.48

29.43%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

7.84%

EBIT Growth (5y)

2.72%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt is too low

Net Debt to Equity (avg)

-0.05

Sales to Capital Employed (avg)

3.60

Tax Ratio

26.68%

Dividend Payout Ratio

17.91%

Pledged Shares

Institutional Holding

0.02%

ROCE (avg)

15.74%

ROE (avg)

12.58%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.75

EV to EBIT

12.25

EV to EBITDA

7.72

EV to Capital Employed

1.70

EV to Sales

0.47

PEG Ratio

3.09

Dividend Yield

ROCE (Latest)

13.87%

ROE (Latest)

11.48%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Bearish

Moving Averages

Bearish (Daily)

KST

Bullish

Bearish

Dow Theory

Mildly Bullish

Mildly Bearish

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

8What is working for the Company

DIVIDEND PAYOUT RATIO(Y)

Highest at 37.93%

DIVIDEND PER SHARE(HY)

Highest at JPY 67.88

RAW MATERIAL COST(Y)

Fallen by 1.06% (YoY

NET SALES(Q)

Highest at JPY 289,203 MM

NET PROFIT(Q)

Highest at JPY 9,398.03 MM

EPS(Q)

Highest at JPY 117.31

-17What is not working for the Company

DEBT-EQUITY RATIO (HY)

Highest at 6.04 %

INTEREST COVERAGE RATIO(Q)

Lowest at 6,593.77

DEBTORS TURNOVER RATIO(HY)

Lowest at 67.88 times

INTEREST(Q)

Highest at JPY 257 MM

Here's what is working for COSMOS Pharmaceutical Corp.

Dividend per share

Highest at JPY 67.88 and Grown

In each year in the last five years

MOJO Watch

Company is distributing higher dividend from profits generated

DPS (JPY)

Dividend Payout Ratio

Highest at 37.93% and Grown

In each year in the last five years

MOJO Watch

Company is distributing higher proportion of profits generated as dividend

DPR (%)

Net Sales

Highest at JPY 289,203 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (JPY MM)

Net Profit

Highest at JPY 9,398.03 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (JPY MM)

EPS

Highest at JPY 117.31

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (JPY)

Raw Material Cost

Fallen by 1.06% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation

Highest at JPY 6,615 MM

in the last five periods

MOJO Watch

The expenditure on assets done by the company may have gone into operation

Depreciation (JPY MM)

Here's what is not working for COSMOS Pharmaceutical Corp.

Interest

At JPY 257 MM has Grown at 140.19%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (JPY MM)

Interest Coverage Ratio

Lowest at 6,593.77

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Debt-Equity Ratio

Highest at 6.04 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Interest

Highest at JPY 257 MM

in the last five periods and Increased by 140.19% (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (JPY MM)

Debtors Turnover Ratio

Lowest at 67.88 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Footer loading